Optima Health has announced a positive trading update this morning for the 12 months to end March 2026, with full‑year adjusted EBITDA expected to come in c10% ahead of consensus of £18.1m (Cavendish estimate: £17.9m). As a reminder, this figure includes the final settlement relating to a previously disclosed procurement challenge, which concluded that a contract should have been awarded to Optima during a prior procurement process. The settlement has been recognised as other operating income, w ....
